Cycloxygenase-2 (COX2) expression in transitional cell carcinoma of the bladder does not confer independent prognostic properties

被引：0
|
作者：
Czachorowski, M. [1 ]
Real, F. X. [2 ]
Lloreta, J. [3 ]
Silverman, D. T. [4 ]
Morente, M. [5 ]
Kishore, S. [3 ]
Kogevinas, M. [3 ]
Malats, N. [1 ]
机构：
[1] CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain
[2] CNIO, Eptithelial Carcinogenesis Grp, Madrid, Spain
[3] IMIM, Barcelona, Spain
[4] NCI, Bethesda, MD 20892 USA
[5] CNIO, Biobank Grp, Madrid, Spain
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)70907-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
99
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [31] Gli2 Expression and Human Bladder Transitional Carcinoma Cell Invasiveness
    Mechlin, Clay W.
    Tanner, Matthew J.
    Chen, Mengqian
    Buttyan, Ralph
    Levin, Robert M.
    Mian, Badar M.
    JOURNAL OF UROLOGY, 2010, 184 (01) : 344 - 351
  • [32] Simultaneously targeting epidermal growth factor receptor (EGFR) and cycloxygenase-2 (COX-2) as a potential novel approach for chemoprevention of squamous cell carcinoma of the head and neck (SCCHN)
    Shin, DM
    Zhang, X
    Wang, ZQ
    Li, MF
    Grandis, JR
    Chen, ZG
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1318S - 1318S
  • [33] Microvessel density (MVD) and cycloxygenase-2 (COX-2)/β-catenin interaction are associated with relapse in patients with transitional carcinoma receiving adjuuvant chemotherapy with paclitaxel/carbplatino:: A Hellenic Cooperative Oncology Group (HECOG) study
    Bamias, A.
    Yriakou, F. K.
    Chorti, M.
    Kavantzas, N.
    Noni, A.
    Kyroudi-Voulgari, A.
    Rontoyianni, D.
    Kastritis, E.
    Xiros, N.
    Patsouris, E. S.
    Murray, S.
    Tamvakis, N.
    Dimopoulos, M. A.
    ANTICANCER RESEARCH, 2008, 28 (4C) : 2479 - 2486
  • [34] Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder
    Ristimäki, A
    Nieminen, O
    Saukkonen, K
    Hotakainen, K
    Nordling, S
    Haglund, C
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (03) : 849 - 853
  • [35] Cyclooxygenase-2 expression in invasive transitional cell carcinoma of the urinary bladder
    Yamada, Yoshiaki
    Nakamura, Kogenta
    Inoue, Yasusuke
    Naruse, Katsuya
    Aoki, Shigeyuki
    Taki, Tomohiro
    Tobiume, Motoi
    Zennami, Kenji
    Katsuda, Remi
    Hara, Kouji
    Kyoku, Inbou
    Mitsutake, Noriko
    Arakawa, Maki
    Saito, Hiroko
    Hasegawa, Takaaki
    Noguchi, Hiroshi
    Honda, Nobuaki
    MOLECULAR MEDICINE REPORTS, 2008, 1 (06) : 791 - 795
  • [36] Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder
    Shiina, H
    Igawa, M
    Urakami, S
    Honda, S
    Shirakawa, H
    Ishibe, T
    JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (05) : 395 - 399
  • [37] Clinical features, survival times and COX-1 and COX-2 expression in cats with transitional cell carcinoma of the urinary bladder treated with meloxicam
    Bommer, Nicholas X.
    Hayes, Alison M.
    Scase, Timothy J.
    Gunn-Moore, Danielle A.
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2012, 14 (08) : 527 - 533
  • [38] Previous history of bladder cancer is an independent prognostic factor for upper tract transitional cell carcinoma
    Kikuchi, Eiji
    Miyajima, Akira
    Nakagawa, Ken
    Oya, Mototsugu
    Ohigashi, Takashi
    Nakashima, Jun
    Murai, Masaru
    JOURNAL OF UROLOGY, 2007, 177 (04) : 135 - 135
  • [39] Aloe vera gel stimulates PGE2 production and COX2 expression in gastric carcinoma cell lines
    Smith, GV
    Langmead, L
    Rampton, DS
    GUT, 2002, 50 : A64 - A64
  • [40] Expression of cyclooxygenase-2 (COX-2) is an independent prognostic factor in human ovarian carcinoma.
    Denkert, C
    Berger, S
    Pest, S
    Koch, I
    Köbel, M
    Schwabe, M
    Siegert, A
    Reles, A
    Hauptmann, S
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3813S - 3814S
12345